Brandt M, Levy M A
Department of Medicinal Chemistry, Smith Kline & French Laboratories, King of Prussia, Pennsylvania 19406.
Biochemistry. 1989 Jan 10;28(1):140-8. doi: 10.1021/bi00427a021.
Several 3-oxo-4-aza steroids (1) have been identified as inhibitors of the 3 beta-hydroxy-delta 5-steroid dehydrogenase/3-keto-delta 5-steroid isomerase catalyzed conversion of pregnenolone to progesterone. By kinetically decoupling the two enzyme activities isolated from bovine adrenal cortex, it has been demonstrated that inhibition by 1 occurs through interference of both activities. A preferred ordered association of substrates to the 3 beta-hydroxy-delta 5-steroid dehydrogenase in which the cofactor binds prior to steroid was determined by isotope exchange at equilibrium. With this result, the dead-end inhibition patterns of 1 with the dehydrogenase were interpreted to originate from a preferred association of inhibitor within an enzyme ternate containing NADH; this proposal is supported by data from multiple inhibition analysis indicating synergistic binding of NADH and 1. Similarly, inhibition of the 3-keto-delta 5-steroid isomerase by the 3-oxo-4-aza steroids was enhanced in the presence of the positive effector NADH. On the basis of pH profiles upon Vm, Vm/Km, and 1/Ki for both enzyme activities, inhibition is proposed to result from the structural similarity of 1 to intermediate states formed upon enzyme catalysis.
几种3-氧代-4-氮杂甾体(1)已被确定为3β-羟基-δ5-甾体脱氢酶/3-酮-δ5-甾体异构酶催化孕烯醇酮转化为孕酮的抑制剂。通过对从牛肾上腺皮质分离出的两种酶活性进行动力学解耦,已证明1的抑制作用是通过干扰两种活性而发生的。通过平衡时的同位素交换确定了底物与3β-羟基-δ5-甾体脱氢酶的优先有序结合,其中辅因子在甾体之前结合。根据这一结果,1对脱氢酶的终产物抑制模式被解释为源于抑制剂在含有NADH的酶三元复合物中的优先结合;这一推测得到了多重抑制分析数据的支持,这些数据表明NADH和1具有协同结合作用。同样,在正效应物NADH存在的情况下,3-氧代-4-氮杂甾体对3-酮-δ5-甾体异构酶的抑制作用增强。基于两种酶活性的Vm、Vm/Km和1/Ki的pH曲线,推测抑制作用是由于1与酶催化形成的中间状态的结构相似性所致。